Triomics raised a $22 million Series B to expand AI tools for oncology clinical workflows and trial matching.

Isomorphic Labs, a Google DeepMind spinoff, will soon start human trials of drugs designed using its Nobel Prize–winning AI protein-folding technology.

Demis Hassabis reveals 17 AI drug development projects at Davos, predicting robotics breakthrough and golden age of scientific discovery.

2026 is set to be a pivotal year for AI in pharmaceuticals, as AI-powered simulations and richer data are expected to reshape clinical trial design, improving efficiency and data quality.